Financial
information
Hofseth BioCare aim to serve the financial market with precise and relevant information about the company to ensure that the share price reflects the underlying values and future prospects. In this section you will find the latest news, presentations, reports and other useful information.
Stock Exchange Notices
- 2017-10-11: Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE, PRIMARY INSIDER IN HOFSETH BIOCARE ASA
- 2017-10-10: Hofseth Biocare ASA: Financial Update
- 2017-09-15: Hofseth Biocare ASA: CHANGES IN BOARD OF DIRECTORS - OLA HOLEN TO FUNCTION AS NEW INTERIM CHAIRMAN
- 2017-08-30: Hofseth Biocare ASA: Mandatory notification of trade, primary insider in HBC
- 2017-08-25: Hofseth Biocare ASA: HBC Second Quarter 2017 Financial report
- 2017-08-14: Hofseth Biocare ASA: Roger Hofseth new CEO in HBC
- 2017-05-29: Hofseth Biocare ASA : Completed annual general meeting
- 2017-05-11: Hofseth Biocare ASA: First Quarter 2017 Financial Report
- 2017-05-04: Hofseth Biocare ASA: Call for Annual General Meeting
- 2017-03-31: Hofseth Biocare ASA: HBC Annual Report 2016 approved and completes sale and long-term leaseback contracts
Archive
Why Hofseth BioCare?
- New advanced proprietary process technology
- Producing premium products
- Attractive market proposition
- State of the art production facilities
- Attractive partner model for further growth
- Upside potential within pharma segments
- Management with highly relevant experience
